Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium

13Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Of 233 erythromycin-resistant pneumococcal isolates collected in Belgium in 1999-2000, 89.7% carried the erm(B) gene, 6% the mef(A) gene, and 3.5% erm(B) plus mef(A). Two isolates contained neither erm(B) nor mef(A); one contained an erm(A) subclass erm(TR) gene, while the other contained an A2058G mutation in domain V of the 23S rRNA gene. Of 209 erm(B)-positive isolates, 191 had clindamycin MICs >16 mg/L and 18 had MICs ≤16 mg/L. Mef(A)-positive isolates all displayed the M resistance phenotype. Telithromycin remained active against erythromycin-resistant isolates, with the highest telithromycin MIC50 being found in mef(A)-positive isolates. No difference in the prevalence of different resistance mechanisms was observed compared to isolates collected in 1995-1997. © 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Van Eldere, J., Meekers, E., Lagrou, K., Massonet, C., Canu, A., Devenyns, I., … Leclercq, R. (2005). Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium. Clinical Microbiology and Infection, 11(4), 332–334. https://doi.org/10.1111/j.1469-0691.2005.01077.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free